{"schema_version":"secwatch.filing_event.v1","accession":"0000719135-24-000023","form_type":"8-K","ticker":"APYX","cik":"0000719135","company_name":"Apyx Medical Corp","filed_at":"2024-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.765466+00:00","generated_at":"2026-06-02T07:33:40.534045+00:00","sec_items":["1.01","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Apyx Medical appoints Stavros Vizirgianakis as Chairman; founder Andrew Makrides retires after 40+ years","bullets":["Andrew Makrides retired as Chairman effective May 7, 2024, after serving since 1982.","Stavros Vizirgianakis appointed Chairman and director to fill vacancy; term expires at 2024 annual meeting.","Vizirgianakis is a former CEO of Misonix and current director of Xtant Medical and Medinotec.","Agreement includes standstill until 2025 annual meeting, limiting ownership to 9.9% and requiring vote with Board.","Board and Vizirgianakis will cooperate to identify an additional director within six months if he holds 5%+ shares."],"urls":{"canonical":"https://secwatch.observer/filing/0000719135-24-000023","json":"https://secwatch.observer/filing/0000719135-24-000023.json","markdown":"https://secwatch.observer/filing/0000719135-24-000023.md","text":"https://secwatch.observer/filing/0000719135-24-000023.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/719135/000071913524000023/0000719135-24-000023-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/719135/000071913524000023/apyx-20240507.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T07:33:40.534045+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4dfdf26021","claim":"Andrew Makrides retired as Chairman of the Board at Apyx Medical Corp.","evidence_excerpt":"On May 7, 2024, Andrew Makrides announced his retirement as a director and Chairman of the Board, effective on the same date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/719135/000071913524000023/0000719135-24-000023-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Chairman of the Board"}],"fact_type":"executive_change"},{"claim_id":"f8a82d1f51","claim":"Stavros Vizirgianakis was appointed as Director and Chairman of the Board at Apyx Medical Corp.","evidence_excerpt":"On May 7, 2024, the Board appointed Mr. Vizirgianakis to serve as a director and Chairman of the Board, to fill the vacancy created by the retirement of Andrew Makrides.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/719135/000071913524000023/0000719135-24-000023-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director and Chairman of the Board"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}